Evidence map›Paper›PMID 33117339›Full record

Trial reportFrontiers in immunology2020

Polymorphism in the Promoter Region of the

Paula Keiko Sato, Felipe Delatorre Busser, Flávia Mendes da Cunha Carvalho, Alexandra Gomes Dos Santos, Aya Sadahiro, Constancia Lima Diogo, Adriana Satie Gonçalves Kono, Maria Luiza Moretti, Olinda do Carmo Luiz, Maria Aparecida Shikanai-Yasuda

Open access · goldAbstract readClinical Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Genome-Wide Association Study RevealsJournal of fungi (Basel, Switzerland) · 2023
    Article
  4. Expression Profiles of the OvineFrontiers in veterinary science · 2022
    Article
  5. Paracoccidioidomycosis Protective Immunity.Journal of fungi (Basel, Switzerland) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Paula Keiko SatoLaboratory of Medical Investigation in Immunology (LIM48), Faculdade de Medicina, Hospital das Clínicas, University of São Paulo, São Paulo, Brazil.
Felipe Delatorre BusserLaboratory of Medical Investigation in Immunology (LIM48), Faculdade de Medicina, Hospital das Clínicas, University of São Paulo, São Paulo, Brazil.
Flávia Mendes da Cunha CarvalhoLaboratory of Medical Investigation in Immunology (LIM48), Faculdade de Medicina, Hospital das Clínicas, University of São Paulo, São Paulo, Brazil.
Alexandra Gomes Dos SantosLaboratory of Medical Investigation in Immunology (LIM48), Faculdade de Medicina, Hospital das Clínicas, University of São Paulo, São Paulo, Brazil.
Aya SadahiroDepartment of Parasitology, Instituto de Ciências Biológicas, Federal University of Amazonas, Manaus, Brazil.
Constancia Lima DiogoLaboratory of Medical Investigation in Immunology (LIM48), Faculdade de Medicina, Hospital das Clínicas, University of São Paulo, São Paulo, Brazil.
Adriana Satie Gonçalves KonoInfectious Diseases Division, Hospital das Clínicas, University of São Paulo, São Paulo, Brazil.
Maria Luiza MorettiFaculdade de Ciências Médicas, Hospital das Clínicas, State University of Campinas, Campinas, Brazil.
Olinda do Carmo LuizDepartment of Preventive Medicine, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil.
Maria Aparecida Shikanai-YasudaLaboratory of Medical Investigation in Immunology (LIM48), Faculdade de Medicina, Hospital das Clínicas, University of São Paulo, São Paulo, Brazil.
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo · BRHospital de Clínicas da Unicamp · BRUniversidade de São Paulo · BRUniversidade Federal do Amazonas · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Paracoccidioidomycosis (PCM) is an important endemic, systemic disease in Latin America caused by

Indexed as

Interleukin-18ParacoccidioidomycosisPromoter Regions, GeneticSeverity of Illness IndexFemaleHumansMaleMiddle AgedParacoccidioidesT-Lymphocytes, Helper-InducerIL18 protein, humanInterleukin-18clinical forms of paracoccidioidomycosisIFNGR1IL12AIL18Paracoccidioides spp.paracoccidioidomycosissingle nucleotide polymophism

Identifiers

PMID33117339
PMCPMC7559583
OpenAlexW3089950138

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.